Evidence map›Paper›PMID 23063509›Full record

ArticleThe American journal of pathology2012

Altered decidual DC-SIGN+ antigen-presenting cells and impaired regulatory T-cell induction in preeclampsia.

Peter Hsu, Brigitte Santner-Nanan, Jane E Dahlstrom, Mitali Fadia, Arin Chandra, Michael Peek, Ralph Nanan

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in The American journal of pathology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 84 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed, 1 pooled it
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

84 citing papers in PubMed, 1 synthesis or guideline pooled it, 180 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Frontiers in immunology · 2026
    Article
  6. Review
  7. Article
  8. Arginine Metabolism in Decidual Macrophages During Pregnancy.American journal of reproductive immunology (New York, N.Y. : 1989) · 2025
    Review
  9. Regulatory KIRScience translational medicine · 2025
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. CD4Frontiers in immunology · 2024
    Article
  16. Air pollution and pregnancy.Seminars in perinatology · 2023
    Article
  17. Article
  18. Article
  19. The Role of ncRNAs in the Immune Dysregulation of Preeclampsia.International journal of molecular sciences · 2023
    Review
  20. Review

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Peter HsuNepean Center for Perinatal Care, Sydney Medical School Nepean, The University of Sydney, Penrith, Australia.
Brigitte Santner-Nanan
Jane E Dahlstrom
Mitali Fadia
Arin Chandra
Michael Peek
Ralph Nanan
The University of Sydney · AUAustralian National University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Regulatory T (Treg) cell expansion is required for tolerance of the semi-allogeneic fetus in healthy pregnancy and impaired in preeclampsia in humans. However, the reasons remain unknown. Herein, we show that expansion of CD4(+)Helios(-)Foxp3(+) adaptive Treg (iTreg) cells, rather than CD4(+)Helios(+)Foxp3(+) natural Treg cells, accounts for this expansion in healthy pregnancy. This expansion is even more pronounced in the decidua, where there is an overrepresentation of iTreg cells. In preeclampsia, however, there is impaired systemic iTreg cell expansion, associated with a lack of iTreg cell overrepresentation in the decidua. Because decidual antigen-presenting cells (APCs) may be important for iTreg cell induction, we studied decidual CD14(+) APCs using immunohistochemistry and flow cytometry. We show that decidual CD14(+)DC-SIGN(+) APCs are closely associated with Foxp3(+) Treg cells. Furthermore, CD14(+)DC-SIGN(+) cells display a distinct phenotype compared with their CD14(+)DC-SIGN(-) counterparts. In particular, they have increased expression of tolerogenic molecules, HLA-G, and immunoglobulin-like transcript 4. In vitro, CD14(+)DC-SIGN(+) APCs from healthy pregnant women induced iTreg cells significantly more efficiently than CD14(+)DC-SIGN(-) APCs. Conversely, in preeclampsia, both CD14(+)DC-SIGN(+) and CD14(+)DC-SIGN(-) APCs induced iTreg cells poorly. These results suggest that decidual CD14(+)DC-SIGN(+) APCs may play important roles in iTreg cell induction, a process that is defective in preeclampsia and likely contributes to its pathogenesis.

Indexed as

Antigen-Presenting CellsCell Adhesion MoleculesDC-Specific ICAM-3 Grabbing NonintegrinDeciduaFemaleForkhead Transcription FactorsHealthHLA-G AntigensHumansIkaros Transcription FactorImmunohistochemistryLectins, C-TypeLipopolysaccharide ReceptorsModels, ImmunologicalPhenotypePre-EclampsiaCell Adhesion MoleculesDC-Specific ICAM-3 Grabbing NonintegrinForkhead Transcription FactorsFOXP3 protein, humanHLA-G AntigensIkaros Transcription FactorIKZF2 protein, humanLectins, C-TypeLipopolysaccharide ReceptorsReceptors, Cell Surface

Identifiers

PMID23063509
OpenAlexW1967640877

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.